GLP-1 receptor agonists
US$ 24.87
pharmacy that compounds semaglutide Injection | Starts at $149/mo As Ozempic demand climbs, patients
Description
However, a less-discussed concern is the loss of muscle, which is equally as concerning, so lets dive into that here
Most reports of this nature are anecdotal or related to other factors
In the clinical trials so far, blood sugar effects have been manageable (retatrutide actually improved blood sugar in diabetic patients), and muscle loss has been proportional to weight loss
Danuglipron (from Pfizer) showed mixed results and faced development challenges
EVEN THOUGH I ALREADY PAID FOR IT AND NEVER GOT IT
But, its essential to be aware of the potential risks, such as contamination or dosing errors
